Molecular-targeted therapy may benefit Japanese renal-cell carcinoma patients who have memorial Sloan Kettering cancer center intermediate-risk classification: A multi-institutional cooperative study
著者
T. Shimabukuro;K. Nagao;H. Matsuyama;S. Sakano;N. Yamamoto;T. Nasu;M. Yamamoto;K. Takai;S. Yoshihiro;K. Oba
掲載雑誌名
Nishinihon Journal of Urology
学部・研究科名
医学部
抄録
URL
本サイトへの掲載日
2016-2-23
Copyright(C) Yamaguchi University Library. All rights reserved
